<DOC>
	<DOCNO>NCT01967225</DOCNO>
	<brief_summary>The aim study see safety efficacy BAY1192631 use treatment skin soft tissue infection ( SSTI ) SSTI-related bacteremia .</brief_summary>
	<brief_title>Safety Efficacy BAY1192631 Japanese Patients With Methicillin-resistant Staphylococcus Aureus ( MRSA ) Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Torezolid</mesh_term>
	<criteria>Inclusion Criteria Suspected confirm Methicillinresistant Staphylococcus aureus ( MRSA ) infection Japanese Male female patient age 18 year Diagnosis Skin soft tissue infection MRSA either suspect confirmed major cause infection , with/without SSTI ( skin soft tissue infection ) derive MRSA bacteremia suspect Having receive systemic antibacterial potentially effective MRSA &gt; /=24 hour within 3 day prior first infusion study drug , received/expected receive medication within 24 hour prior first infusion , unless antibacterial therapy &gt; /=72 hour prove ineffective lack appropriate potency ( resistant ) MRSA . Moribund clinical condition death likely within first 3 day study drug treatment History significant allergy intolerance linezolid BAY1192631 Known suspect human immunodeficiency virus ( HIV ) infection CD4+ Tcell count &lt; 200/Î¼L Chronic treatment immunosuppressive drug Active tuberculosis nontuberculous mycobacteriosis need medical treatment Current anticipate neutropenia neutrophil count &lt; 1,000/ mm3 Alanine aminotransferase ( ALT ) Aspartate aminotransferase ( AST ) &gt; /= 8 time upper limit reference range OR moderate severe hepatic disease Child Pugh score &gt; /=10 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Methicillin Resistant Staphylococcus Aureus ,</keyword>
	<keyword>Skin soft tissue infection ,</keyword>
	<keyword>Bacteremia ,</keyword>
	<keyword>Tedizolid</keyword>
</DOC>